DIABIL-2

Ultra-low dose of IL-2 for the treatment of recently diagnosed type 1 diabetes

CoordinatorUniversity of Basel ; Assistance Publique -Hopitaux De Paris ; DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG ; INSERM TRANSFERT SA ; ACADEMISCH ZIEKENHUIS LEIDEN ; THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE ; Iltoo Pharma (France)
Grant period2012-10-01 - 2019-03-31
Funding bodyEuropean Union
Call numberFP7-HEALTH-2012-INNOVATION-1
Grant number305380
IdentifierG:(EU-Grant)305380

     

Recent Publications

There are no publications


 Record created 2014-10-20, last modified 2023-02-28



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)